CTOs on the Move

Checkmate Pharmaceuticals

www.checkmatepharma.com

 
Checkmate Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat cancer. Checkmate`s product candidate, CMP-001, is an advanced generation TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body`s innate immune system to attack tumors in combination with other therapies.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Checkmate Pharmaceuticals raised $20M on 08/12/2015
Checkmate Pharmaceuticals raised $27M on 06/15/2017
Checkmate Pharmaceuticals raised $22M on 12/12/2018
Checkmate Pharmaceuticals raised $15.9M on 01/27/2020
Checkmate Pharmaceuticals raised $85M on 06/10/2020

Similar Companies

Saniona

Saniona is a rare disease biopharmaceutical company focused on research, development and commercialization of treatments for the central nervous system. The company has four programs in clinical

Medicis Pharmaceutical Corporation

Medicis Pharmaceutical Corporation (Medicis) is an independent specialty pharmaceutical company focused primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the United States of

MediSpin Inc

MediSpin Inc is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Leiters

Leiters is a FDA-registered 503B outsourcing provider of high quality ophthalmology and hospital-based services. We are committed to providing healthcare professionals and their patients with high quality medications.

Gala Therapeutics

Gala Therapeutics is a medical devices company developing therapies to improve survival, quality of life, and outcomes for patients with pulmonary diseases.